Bioptimus Raises $41M to Develop a "GPT for Biology"

Bioptimus Raises $41M to Develop a "GPT for Biology"

Paris, France – January 14, 2025 – Bioptimus, a pioneering French AI startup, has secured a substantial $41 million in funding to spearhead the development of a groundbreaking foundational AI model specifically designed for biological applications. This significant investment follows a successful $35 million seed round just a year ago, bringing the company's total funding to an impressive $76 million. This rapid influx of capital underscores the immense potential of Bioptimus's technology and the burgeoning interest in AI-driven solutions within the life sciences sector. A "GPT for Biology" Drawing inspiration from OpenAI's revolutionary language model, ChatGPT, Bioptimus aims to create a similarly powerful AI system, but with a singular focus on biological domains. While ChatGPT excels at generating human-like text, Bioptimus seeks to leverage AI to simulate biological processes, predict disease outcomes, and accelerate the development of novel treatments. "Ess…